Diversification of existing reference phantoms in Nuclear Medicine: Calculation of Specific Absorbed Fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of 18F-FDG

Matthias Blaickner; Peter Kindl

Diversification of existing reference phantoms in Nuclear Medicine: Calculation of Specific Absorbed Fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of 18F-FDG

Matthias Blaickner
, Peter Kindl

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	767-782
Number of pages	16
Journal	Cancer Biotherapy & Radiopharmaceuticals
Volume	23
Issue number	6
Publication status	Published - 2008

Research Field

Not defined

Cite this

@article{bab7c959b34842739fc4e5140a9224ba,

title = "Diversification of existing reference phantoms in Nuclear Medicine: Calculation of Specific Absorbed Fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of 18F-FDG",

author = "Matthias Blaickner and Peter Kindl",

note = "Mail Mitterecker",

year = "2008",

language = "English",

volume = "23",

pages = "767--782",

number = "6",

}

Diversification of existing reference phantoms in Nuclear Medicine: Calculation of Specific Absorbed Fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of 18F-FDG. / Blaickner, Matthias; Kindl, Peter.
In: Cancer Biotherapy & Radiopharmaceuticals, Vol. 23, No. 6, 2008, p. 767-782.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Diversification of existing reference phantoms in Nuclear Medicine: Calculation of Specific Absorbed Fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of 18F-FDG

AU - Blaickner, Matthias

AU - Kindl, Peter

N1 - Mail Mitterecker

PY - 2008

Y1 - 2008

M3 - Article

VL - 23

SP - 767

EP - 782

JO - Cancer Biotherapy & Radiopharmaceuticals

JF - Cancer Biotherapy & Radiopharmaceuticals

IS - 6

ER -